CUL4B and posterior cortical atrophy: Notably, Kaplan−Meier survival analysis revealed that PCa patients with CUL4B overexpression had a faster progression to biochemical recurrence (n = 421, Fig. 1f) and clinical recurrence (n = 305, Fig. 1g).